Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse modelviathe mTORC1 and cell-cycle-associated CDK1/cyclin axis-Reference-Cited by-同舟云学术

Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse modelviathe mTORC1 and cell-cycle-associated CDK1/cyclin axis

Published:2017-02-28 Issue:8 Volume:21 Page:1619-1635
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J. Cell. Mol. Med.

Author:

Li Ao¹²,Fan Song¹,Xu Yuchen¹,Meng Jialin¹,Shen Xufeng¹,Mao Jun¹,Zhang Li¹,Zhang Xiansheng¹,Moeckel Gilbert³,Wu Dianqing⁴,Wu Guanqing¹²,Liang Chaozhao¹

Affiliation:

1. Department of Urology; PKD Center; The First Affiliated Hospital of Anhui Medical University; Hefei Anhui Province China

2. State Key Laboratory of Molecular Oncology; Cancer Hospital and Institute; Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing China

3. Department of Pathology; Yale University School of Medicine; New Haven CT USA

4. Department of Pharmacology; Yale University School of Medicine; New Haven CT USA

Funder

National 973 Program

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcmm.13091/fullpdf

Reference86 articles.